this study confirms that the clinical practice of monitoring total phenytoin plasma concentrations is sufficient , since the unbound phenytoin fraction has only a 2-fold interindividual variation in epileptic patients , provided that they do not suffer from renal or hepatic disease .
C0031507
phenytoin
C0014544
epileptic